Name: Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (Tandem Diabody)
SKU: T-BSDB-173
Rating: 5 (1 reviews)

Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy.

Datasheet INQUIRY

Specifications

Targets

IL13 & IL4

Type

Tandem Diabody

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Idiopathic pulmonary fibrosis

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

IL13

Gene ID

3596

UniProt ID

P35225

Alternative Names

IL13; interleukin 13; P600; IL-13; interleukin-13

Target 2

IL4

Gene ID

3565

UniProt ID

D4HNR6

Alternative Names

IL4; interleukin 4; BSF1; IL-4; BCGF1; BSF-1; BCGF-1; interleukin-4; binetrakin; pitrakinra; B cell growth factor 1; interleukin 4 variant 2; B_cell stimulatory factor 1; lymphocyte stimulatory factor 1

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (Tandem Diabody) (T-BSDB-173). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-173)

Specifications

Targets

Customer Reviews and Q&As